In patients with neurodegenerative diseases, such as AD and ALS, NADPH oxidase 2 (NOX2) in serum is increased compared to control patients, suggesting that NOX2 enzyme activity is significantly increased in these cohorts. This evidence concerns the gene CYBB and Alzheimer disease.